News
News

The latest updates from AFAR.

Grantees in the News: D. Holtzman & C. Rosano Lead Studies Connecting Diabetes to Alzheimer's

May 27
2015

Grantees in the News: D. Holtzman & C. Rosano Lead Studies Connecting Diabetes to Alzheimer's

On May 25, 2015, the Wall Street Journal profiled two studies, led by 1995 Beeson Scholar, Dr. David Holtzman and 2006 Beeson Scholar Dr. Caterina Roseano, on a correlation between diabetes and an increased risk of developing Alzheimer’s disease. Working at the Washington University in St. Louis, Dr. Holtzman found that raising blood sugar levels in mice corresponded with increased production of the Alzheimer’s associated protein amyloid beta. At the University of Pittsburgh, Dr. Roseano’s team found that individuals with Type 1 diabetes had significantly more brain lesions and slower cognitive function compared to a similarly aged control group. …


View MoreREAD MORE


Grantees in the News: Reisa Sperling and Scott Turner Use New Image Technology in Groundbreaking Study

May 27
2015

Grantees in the News: Reisa Sperling and Scott Turner Use New Image Technology in Groundbreaking Study

On May 25, 2015, ABC News reported on a novel technique utilized by 2003 Beeson Scholar, Dr. Reisa Sperling in her Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study to determine whether an experimental drug prevents Alzheimer’s in individuals who are in good health but at high risk of the disease. By using brain-scanning technology, Dr. Sperling and her team have been able to identify Alzheimer’s disease’s two main hallmarks--plaque buildup and tangles in the tau protein--in these individuals. The scans will help researchers determine the effectiveness of the experimental drug. 1998 Beeson Scholar, Dr. R.…


View MoreREAD MORE


InfoAging “Ask the Expert”: Eric Reiman, M.D. on Paths to A Cure for Alzheimer’s

May 22
2015

InfoAging “Ask the Expert”: Eric Reiman, M.D. on Paths to A Cure for Alzheimer’s

AFAR is excited to announce the latest addition to our “Ask the Expert” series on InfoAging.org.  In an exclusive interview, Eric Reiman, M.D., of the Banner Alzheimer’s Institute and the Arizona Azheimer’s Consortium, weighs in on the paths to a cure for Alzheimer’s. He also shares insights from his collaborative, global research through the Alzheimer’s Prevention Initiative.  Read the whole feature on InfoAging here.


View MoreREAD MORE


Board Member in the News: Norman Relkin on Medical Marijuana Pills as Dementia Treatment

May 15
2015

Board Member in the News: Norman Relkin on Medical Marijuana Pills as Dementia Treatment

On May 13, 2015, Health Day featured commentary by Board Member, Dr. Norman Relkin on a new study showing medical marijuana pills may not be an effective treatment for dementia. A small study found that individuals given medical marijuana pills experienced no better easing of agitation, aggression, and wandering than those given placebo pills.  Considering the this new treatment’s potential, Dr. Relkin stated: “Right now, there are no medications specifically approved for these types of symptoms…the medications we use are all 'borrowed' from the armamentarium for other conditions that are similar to these dementia symptoms." …


View MoreREAD MORE


Grantee in the News: Adam Gazzaley Finds Computer Game May Improve Cognitive Function

May 12
2015

Grantee in the News: Adam Gazzaley Finds Computer Game May Improve Cognitive Function

On May 11, 2015, the New York Times featured two-time AFAR Grantee Dr. Adam Gazzaley’s research demonstrating that use of a computer game may help to enhance older adults’ ability to multitask. Dr. Gazzaley and his team found that adults aged 60-85 who were trained on the game NeuroRacer saw improvements in their working memory and in their ability to multitask and maintain sustained attention.  The improvements remained for at least six months. The article cautions readers to look for quality research studies before investing in products that claim to improve aging brain function, but this new…


View MoreREAD MORE




BACK TO TOPBACK TO TOP